The metabolic demands of immune cells are altered in such inflammatory diseases as atherosclerosis, and Blimp-1 may regulate the cell survival and function of TRM cells in hypoxic and nutrient-poor environments, found in local lesions such as atherosclerotic plaques. Here, PRDM1 is linked to atherosclerosis.